Filing Details

Accession Number:
0001209191-18-031475
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-18 17:11:06
Reporting Period:
2018-05-17
Accepted Time:
2018-05-18 17:11:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1666790 Michael Bonner 2525 West End Avenue, Suite 950
Nashville TN 37203
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-17 400 $6.12 18,054 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct